What Assoral Treats: Main Uses and Benefits

Assoral (Roxithromycin) is generally considered relevant as a systemic anti-infective agent for managing a range of bacterial infections that cause symptoms related to physical discomfort and systemic imbalance. It may be applied for a variety of mild to moderately severe conditions caused by susceptible organisms, focusing on respiratory, skin, and specific urogenital tract issues.

The medication is commonly used to help with acute symptomatic episodes such as acute bronchitis, tonsillitis, pharyngitis, otitis media, sinusitis, and various skin and soft tissue infections like cellulitis and impetigo. It also plays a role in managing specific infections caused by atypical bacteria, including certain forms of atypical pneumonia and non-gonococcal urethritis.

“The core utility of this medication lies in providing supportive relief during periods when localized pain and systemic discomfort from infection interfere with daily function.”

In these symptomatic contexts, Assoral contributes to easing the symptom clusters that may become intense or disruptive, such as fever, persistent cough, chest congestion, sore throat, and swelling. This supportive approach assists with maintaining functional stability during the acute phases of the illness.

---

Quick Fact: Relief for Localized Pain
Supports the reduction of symptoms related to inflammatory or irritative states in conditions like otitis media (ear pain) and cellulitis (skin redness/swelling).

Official Eligibility Rules for Assoral (Roxithromycin)

The use of Assoral, a macrolide antibiotic, is strictly governed by population eligibility rules established in official regulatory labeling. These rules determine who is allowed, restricted, or prohibited from using the medicine.

---

Absolute Contraindications

Assoral must not be used by individuals who meet the following criteria:

• Macrolide Hypersensitivity: A known allergy or severe sensitivity to roxithromycin or any other macrolide antibiotic.
• Severe Hepatic Impairment: Patients with severely impaired liver function.
• Cardiac Conditions: Individuals with documented congenital or acquired QT interval prolongation.
• Prohibited Medications: Concomitant use with specific drugs, including vasoconstrictive ergot alkaloids (e.g., ergotamine) and certain medications that pose a cardiac risk (e.g., cisapride, pimozide).

---

Restricted and Conditional Use

Population Group	Regulatory Status	Condition Summary
Pediatric Patients	Not Recommended	Children with a body weight of less than 40 kg are generally not recommended for treatment.
Organ Impairment	Use with Caution	Patients with mild to moderate hepatic impairment or renal impairment require cautious use and possible dosage consideration.
Pregnancy/Lactation	Not Recommended	Use is not recommended during pregnancy, and the medicine passes into breast milk during lactation.
Elderly / Specific Comorbidities	Use with Caution	Use requires caution in the elderly and in patients with conditions like Myasthenia Gravis or a risk of cardiac arrhythmias.

Interactions with other medicines and products

Assoral (Roxithromycin) is officially documented to participate in significant drug interactions, primarily through pharmacokinetic mechanisms. It is classified as a moderate inhibitor of the CYP3A4 enzyme and an inhibitor of the P-glycoprotein (P-gp) transporter.

Formal Prohibitions and Contraindications

Co-administration is strictly contraindicated by regulatory authorities with specific medicines due to high risk of severe adverse events:

• Ergot alkaloids (e.g., ergotamine, dihydroergotamine): Prohibition due to risk of severe peripheral ischemia.
• Pimozide and Cisapride: Prohibition due to the significant risk of QTc prolongation and severe cardiac arrhythmias.

Documented Exposure Modification

The inhibitory action leads to increased plasma concentrations or reduced clearance of several co-administered substances. Medicines whose systemic exposure is officially documented to be increased include Midazolam, Cyclosporine, and Theophylline. Co-administration with Digoxin results in increased plasma levels, an effect linked to P-gp inhibition. The co-administration with Warfarin and other oral anticoagulants may lead to a documented prolongation of prothrombin time.

Pharmacodynamic and Contextual Notes

A pharmacodynamic interaction risk exists due to a potential additive QTc prolongation effect when combined with other medicines that affect heart rhythm, such as certain Anti-arrhythmics. Interaction effects are officially documented as potentially exaggerated in patients with severe hepatic impairment. Additionally, official labeling notes that food may delay the absorption of Roxithromycin.

The Mechanism of Roxithromycin

The molecule operates via two distinct pharmacodynamic effects: inhibition of microbial protein synthesis and modulation of the host's inflammatory pathways.

Inhibition of Microbial Protein Synthesis

This domain outlines the primary antibacterial mechanism where the molecule, Roxithromycin, binds precisely to the bacterial 50S ribosomal subunit. This molecular interaction physically blocks the polypeptide exit tunnel, immediately arrests the elongation of polypeptide chains. The resulting physiological consequence is bacteriostasis, characterized by the suppression of bacterial growth and multiplication.

Immunomodulation and Localized Delivery

Beyond its direct action on bacteria, the molecule engages in two critical non-antibacterial mechanisms. Firstly, it accumulates within host immune cells like macrophages, which actively transport high drug concentrations to the site of microbial activity. Secondly, it subtly modulates host inflammatory pathways by suppressing the release of pro-inflammatory mediators (e.g., Interleukin-8). This secondary mechanism promotes the attenuation of excessive mediator release, which modulates the physiological environment in affected tissues.

How Assoral is used is strictly defined by official guidelines, focusing on specific dosage and timing instructions for its active ingredient, Roxithromycin. This systemic anti-infective is approved exclusively for oral administration as a film-coated tablet. The prescribing information mandates that the tablet be taken on an empty stomach—specifically, at least 15 minutes before a meal—to ensure optimal systemic availability. The tablet must be swallowed whole with water.

The administration schedule is based on a total daily intake of 300 mg for adults, achievable through two approved regimens:

Standard Adult Dosing Regimens	Daily Dosage	Frequency
Option 1 (Divided)	150 mg	Twice Daily (b.i.d.)
Option 2 (Single)	300 mg	Once Daily (q.d.)

The duration of the course typically ranges from 5 to 10 days, depending on the specific infection being addressed. A minimum course of 10 days is required for treating certain infections, such as those caused by beta-haemolytic streptococci.

Dose modification is required for specific patient contexts. While no dose adjustment is necessary for older adults or patients with renal impairment, the regimen must be adjusted for individuals with severe hepatic impairment. In this context, the recommended dosage is halved to 150 mg once daily. Procedurally, if a dose is missed, instructions specify that a double dose must not be taken; the patient should simply resume the standard schedule with the next planned dose.

Research Evidence / Overview of Studies for Assoral

---

Evidence for Use in Upper and Lower Respiratory Tract Infections

Assoral (Roxithromycin) has primarily been evaluated in research exploring its role in conditions characterized by acute or disruptive episodes associated with respiratory concerns, such as pharyngitis, tonsillitis, sinusitis, and community-acquired pneumonia. For these conditions, the research generally consists of short-term Randomized Controlled Trials (RCTs) and meta-analyses that was studied for different outcomes in various patient populations.

These studies monitored several key axes, including measurements of clinical success rate (meaning symptoms met criteria for resolution) and the bacteriological eradication rate (confirming the clearance of the infectious organism). Research has explored how symptoms change over time, focusing on outcomes related to physical discomfort and systemic or functional imbalance during the active phase.

---

Research on Chronic Respiratory Conditions

A different research focus was evaluated in settings involving conditions where symptoms may vary in intensity, such as non-cystic fibrosis bronchiectasis. Here, long-term, placebo-controlled pilot trials was studied for to explore the effects of macrolides over extended periods.

These studies monitored outcomes linked to inflammatory or irritative states and explored outcomes reflecting daily functioning or activity level, assessing symptom intensity using tools like Quality of Life (QoL) scores. However, the evidence is limited. These are typically pilot studies, meaning certainty remains low. Larger, longer-term trials are needed to establish clearer patterns.

---

Evidence Gaps and Areas of Uncertainty

Most evidence is concentrated on short-term outcomes, meaning follow-up durations were limited for the vast majority of studies, and long-term effects are not fully established. Additionally, subgroup findings are uncertain for specific patient groups, and research has not broadly examined patient-reported outcomes describing perceived discomfort in all possible patient subsets. The results apply only to the populations studied, and research does not determine whether an individual will respond similarly outside the specific conditions under which the studies were conducted.

Key Studies & References

1. Roxithromycin 150 mg b.i.d. versus amoxycillin 500 mg/clavulanic acid 125 mg t.i.d. for the treatment of lower respiratory tract infections in general practice

Common questions about Assoral (FAQ)

---

Q: Is Assoral a type of antibiotic, painkiller, or something else?

Assoral is described in official product information as a systemic anti-infective drug. Its active substance, roxithromycin, is classified as a macrolide antibiotic which is designed to suppress bacterial growth and multiplication.

---

Q: What's the difference between Assoral and [Commonly Confused Drug A]?

Assoral contains the active substance roxithromycin, which belongs to the macrolide class of antibiotics. When comparing medicines, the class they belong to—like macrolides—is the basis for understanding differences in how they work and their documented interaction profiles.

---

Q: Does Assoral have a risk of dependence or withdrawal symptoms?

Regulatory documents detailing the safety profile of roxithromycin do not list dependence, drug abuse potential, or withdrawal symptoms among the documented adverse reactions or special warnings.

---

Q: Is Assoral available over the counter, or is it prescription-only?

Assoral is a systemic anti-infective drug. Its use, dosage, and duration are based on official prescribing information, meaning it is classified for dispensing only under prescription.

---

Q: Are there any long-term side effects associated with Assoral use?

Official information indicates that most evidence for Assoral is focused on short-term outcomes related to acute infections. Regulatory studies note that long-term effects are not fully established because follow-up durations in most studies have been limited.

---

Q: Can older adults (seniors) safely take Assoral?

Official product information states that no dose adjustment is generally necessary for older adults based on age alone. However, caution is required for patients with pre-existing heart conditions that may increase the risk of QT prolongation (a change in heart rhythm) or arrhythmias.

---

Q: Does Assoral change the way birth control pills work?

Official documents note that roxithromycin does not appear to interact with oral contraceptives containing oestrogens and progestogens, meaning regulatory information indicates the drug does not interfere with their action.

---

Q: Can Assoral be used by people with a history of [Common Condition]?

Assoral is strictly contraindicated for use with specific medicines, such as ergot alkaloids, Pimozide, or Cisapride. It is also not recommended for people with severe liver insufficiency and requires caution for those with conditions predisposing them to heart rhythm issues like QT prolongation.

---

Q: What should I do if I think Assoral is not working for me?

Regulatory information advises that if the symptoms of an infection do not improve within a few days, or if they become worse, the healthcare provider should be informed for evaluation.

---

Q: Are there any special considerations for people with liver disease taking Assoral?

Official prescribing information states that the dosage regimen must be adjusted for individuals with severe hepatic impairment (severe liver problems). The medication is not recommended for those with severe liver insufficiency, and monitoring of liver function is advised for existing mild-to-moderate impairment.

---

Q: How does the mechanism of Assoral compare to [Chemically Similar Drug B]?

Assoral's active ingredient, roxithromycin, is a macrolide antibiotic that works by binding to the bacterial 50S ribosomal subunit, which prevents bacteria from multiplying. This specific mechanism is common to other antibiotics belonging to the macrolide class.

---

Q: Does Assoral affect your energy levels or cause drowsiness?

The official safety profile of roxithromycin includes documented reports of weakness or general discomfort. Dizziness is also listed as a commonly reported side effect that may affect daily activity.

---

Q: How long does Assoral stay in your system after you stop taking it?

The mean elimination half-life of Assoral's active substance is documented in official pharmacokinetic studies to be approximately 10.5 to 12 hours. The half-life describes the time it takes for half of the drug to be eliminated from the plasma.

---

Q: Are there different brand names for the medicine Assoral?

The active substance in Assoral is roxithromycin. This substance is available under multiple brand names across various regulatory regions and may also be available as a generic medicine.

---

Q: Is there a generic version of Assoral available?

The active substance in Assoral, roxithromycin, is available as a generic medicine in addition to various brand-name products in certain regions.

---

Q: Does Assoral interact with alcohol, and what is the risk?

Official patient information for roxithromycin products advises individuals to inform their healthcare provider about alcohol consumption.

---

Q: Can children or teenagers be prescribed Assoral?

Official prescribing information covers the use of roxithromycin tablets for children 4 years and older. However, its use is contraindicated (not permitted) in children under 6 months of age.

---

Q: How is Assoral eliminated from the body?

The elimination of Assoral's active substance is predominantly faecal (through the bile). Only a small percentage of the drug is excreted via the urinary route.

---

Q: What is the physical appearance of the Assoral tablet/capsule?

Assoral is supplied as a film-coated tablet for oral administration. The specific color, shape, and unique markings of the tablet are defined in the product documentation provided by the manufacturer.

---

Q: Are there any known allergic reactions to Assoral ingredients?

Hypersensitivity to the active substance, roxithromycin, or any of the inactive ingredients is a contraindication for its use. Rare, severe allergic reactions such as Anaphylactic shock are documented in the safety profile.

---

Q: Does Assoral affect the results of any common lab tests?

The official safety profile documents reports of transient changes in liver function tests and elevated serum liver enzymes. This indicates the medicine can temporarily alter some blood test results related to liver health.

---

Q: Is Assoral considered a high-risk medication during pregnancy?

Official guidance states that roxithromycin, like other macrolide antibiotics, should only be used during pregnancy when the clinical benefits must outweigh the potential risks. Data regarding small increased risks are insufficient to confirm or rule out with certainty.

--UN

Q: Is it okay to crush or chew Assoral tablets?

Regulatory prescribing information mandates that Assoral tablets must be swallowed whole with water. Crushing or chewing the tablet is advised against, as it may interfere with the medicine's correct absorption.

---

Q: Are there certain groups of people who absolutely cannot use Assoral?

Yes, Assoral is strictly contraindicated for individuals who are also taking specific medicines, including ergot alkaloids, Pimozide, or Cisapride. It is also officially not recommended for people with severe liver insufficiency.

---

Q: Are there any studies comparing Assoral to a placebo?

Research exploring the use of Assoral in chronic respiratory conditions has included placebo-controlled pilot trials to evaluate its effects over extended periods. Most evidence, however, is derived from short-term trials.

---

Q: Is Assoral related to any older, discontinued medications?

Assoral's active ingredient, roxithromycin, is a semi-synthetic antibiotic and is chemically related to the older, founding macrolide antibiotic erythromycin.

The official storage and disposal guidelines for Assoral (Roxithromycin) film-coated tablets define specific temperature, environmental, and container constraints to maintain drug stability.

Storage Conditions

Assoral must be stored at a temperature below 25 C and kept protected from light and moisture. To maintain quality, the tablets must remain in the original container and blister packaging until use. Storage in high-humidity areas, such as a bathroom, is prohibited. The medication must always be stored out of the sight and reach of children to ensure safety.

Disposal

Disposal of unused or expired Assoral must adhere strictly to local pharmaceutical waste regulations. The tablets should not be placed in household trash or poured down a sink. Unwanted medicine must be returned to a pharmacist for appropriate disposal via an approved waste management system.